Reckitt Benckiser Group (LON:RB)‘s stock had its “overweight” rating restated by equities research analysts at JPMorgan Chase & Co. in a report released on Monday, December 18th, StockTargetPrices.com reports. They currently have a GBX 7,500 ($101.71) price objective on the stock. JPMorgan Chase & Co.’s price objective points to a potential upside of 10.29% from the stock’s previous close.
A number of other research analysts have also recently weighed in on the stock. Liberum Capital dropped their price objective on shares of Reckitt Benckiser Group from GBX 8,700 ($117.98) to GBX 8,000 ($108.49) and set a “buy” rating for the company in a report on Wednesday, October 25th. Royal Bank of Canada set a GBX 5,600 ($75.94) price objective on shares of Reckitt Benckiser Group and gave the company a “sell” rating in a report on Friday, October 20th. Jefferies Group dropped their price objective on shares of Reckitt Benckiser Group from GBX 8,150 ($110.52) to GBX 7,500 ($101.71) and set a “hold” rating for the company in a report on Friday, September 15th. Morgan Stanley set a £100 ($135.61) price target on shares of Reckitt Benckiser Group and gave the stock a “buy” rating in a research note on Wednesday, October 11th. Finally, Societe Generale set a GBX 7,800 ($105.78) price target on shares of Reckitt Benckiser Group and gave the stock a “neutral” rating in a research note on Tuesday, September 5th. Two equities research analysts have rated the stock with a sell rating, twelve have issued a hold rating and nine have issued a buy rating to the company’s stock. The company currently has an average rating of “Hold” and a consensus price target of GBX 7,664.55 ($103.94).
Shares of Reckitt Benckiser Group (RB) traded up GBX 14 ($0.19) on Monday, hitting GBX 6,800 ($92.22). 854,576 shares of the company’s stock were exchanged, compared to its average volume of 1,260,000. Reckitt Benckiser Group has a 1-year low of GBX 6,299 ($85.42) and a 1-year high of GBX 8,110.43 ($109.99). The firm has a market capitalization of $47,670.00 and a PE ratio of 2,274.25.
In related news, insider Adrian Nevil Hennah purchased 2,285 shares of the stock in a transaction dated Wednesday, November 8th. The shares were acquired at an average cost of GBX 6,567 ($89.06) per share, with a total value of £150,055.95 ($203,493.29). Also, insider Christopher Sinclair purchased 2,800 shares of the stock in a transaction dated Wednesday, November 1st. The shares were bought at an average cost of GBX 6,597 ($89.46) per share, for a total transaction of £184,716 ($250,496.34).
TRADEMARK VIOLATION WARNING: “Reckitt Benckiser Group (RB) Receives Overweight Rating from JPMorgan Chase & Co.” was first reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this report on another website, it was copied illegally and republished in violation of United States and international copyright law. The correct version of this report can be viewed at https://www.dispatchtribunal.com/2018/01/11/j-p-morgan-chase-co-reiterates-overweight-rating-for-reckitt-benckiser-group-rb.html.
About Reckitt Benckiser Group
Reckitt Benckiser Group plc is a manufacturer and marketer of health, hygiene and home products. The Company’s segments include ENA and DvM. The ENA segment consists of Europe, Russia/Commonwealth of Independent States (CIS), Israel, North America, Australia and New Zealand. The DvM segment consists of North Africa, Middle East (excluding Israel) and Turkey, Africa, South Asia, North Asia, Latin America, Japan, Korea and the Association of Southeast Asian Nations (ASEAN).
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.